OKUR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Onkure Therapeutics Inc (OKUR) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks positive momentum, financial performance is weak, and there are no significant catalysts or signals to support a buy decision.
The stock's MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 55.719, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near a key resistance level (R1: 4.529), and the probability of a decline in the next day, week, and month is high (-0.46%, -10.06%, -15.57%).
NULL identified. There is no recent news or influential trading activity to act as a positive catalyst.
Stock trend analysis indicates a high probability of further declines in the short and medium term.
In Q4 2025, revenue remained at $0, net income dropped to -$13.5M (-61.63% YoY), and EPS fell to -0.99 (-89.42% YoY). Gross margin remained at 0%. The company is not demonstrating growth or profitability.
Analysts maintain a Buy rating but have reduced the price target from $34 to $27, citing concerns about an equity raise in Q2. This indicates cautious optimism but reflects a less favorable outlook.
